Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Amphastar Pharmaceuticals (AMPH) over the last 8 years, with Q3 2025 value amounting to $22.5 million.

  • Amphastar Pharmaceuticals' Change in Acquisitions & Divestments rose 32794.45% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.3 million, marking a year-over-year decrease of 3128.28%. This contributed to the annual value of $126.0 million for FY2024, which is 22629.59% up from last year.
  • As of Q3 2025, Amphastar Pharmaceuticals' Change in Acquisitions & Divestments stood at $22.5 million, which was up 32794.45% from $23.0 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $65.8 million during Q2 2024, with a 5-year trough of -$179000.0 in Q4 2023.
  • In the last 5 years, Amphastar Pharmaceuticals' Change in Acquisitions & Divestments had a median value of $9.1 million in 2022 and averaged $15.0 million.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Change in Acquisitions & Divestments tumbled by 10143.15% in 2023, and later soared by 428100.56% in 2024.
  • Over the past 5 years, Amphastar Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $1.3 million in 2021, then soared by 827.6% to $12.5 million in 2022, then plummeted by 101.43% to -$179000.0 in 2023, then skyrocketed by 4281.01% to $7.5 million in 2024, then skyrocketed by 201.0% to $22.5 million in 2025.
  • Its last three reported values are $22.5 million in Q3 2025, $23.0 million for Q2 2025, and $28.3 million during Q1 2025.